Subcutaneous versus intravenous low-dose IL-2 therapy after autologous transplantation: results of a prospective, non-randomized study.
López-Jiménez J, Pérez-Oteyza J, Munoz A, Parra C, Villalón L, Ramos P, Maldonado M, García-Laraña J, Otheo E, Roldán E, García-Avello A, Odriozola J.
López-Jiménez J, et al. Among authors: garcia larana j, garcia avello a.
Bone Marrow Transplant. 1997 Mar;19(5):429-34. doi: 10.1038/sj.bmt.1700693.
Bone Marrow Transplant. 1997.
PMID: 9052907
Clinical Trial.